Whole body MRI scans in people with certain blood and cancer conditions
Studies whole body MRI scans in adults with lymphoma, prostate, breast, or myeloma conditions.
Plain-language title generated from the registry record
Registry title: Whole Body MRI in Oncology
Key facts
- Where
- Bologna, Meldola, and Milan, ItalySee the 3 sites
Where in Italy
- IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. OrsolaBologna, ItalyTaking people
- IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.Meldola, ItalyTaking people
- IRCCS Istituto Europeo di Oncologia S.r.l.Milan, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Trial code
- NCT06895291
- Record updated
- 30 March 2025
- Original description
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.Read full original descriptionShow less
Whole Body MRI in Oncology
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Inclusion: Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above; Participant is willing and able to give informed consent for participation in the study; Male or Female, aged ≥ 18 years; Life expectancy greater than 3 months.
Exclusion: Patients with MRI-unsafe prostheses and devices; Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.